Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome.

Hartung, Hp; Strasser Fuchs, S; Berger, T; Vass, K; Sindic, C; Dubois, B; Dive, D; Debruyne, J; Metz, L; Rice, G; Duquette, P; Lapierre, Y; Freedman, M; Traboulsee, A; O'Connor, P; Stourac, P; Taláb, R; Zapletalová, O; Kováøová, I; Medová, E; Fiedler, J; Frederiksen, J; Brochet, B; Moreau, T; Vermersch, P; Pelletier, J; Edan, G; Clanet, M; Clavelou, P; Lebrun Frenay, C; Gout, O; Kallela, M; Pirttilä, T; Ruutiainen, J; Koivisto, K; Reunanen, M; Elovaara, I; Villringer, A; Altenkirch, H; Wessel, K; Hartung, Hp; Steinke, W; Kölmel, H; Oschmann, P; Diem, R; Dressel, A; Hoffmann, F; Baum, K; Jung, S; Petereit, Hf; Reske, D; Sailer, M; Köhler, J; Sommer, N; Hohlfeld, R; Henn, Kh; Steinbrecher, A; Tumani, H; Gold, R; Rieckmann, P; Komoly, R; Gács, G; Jakab, G; Csiba, L; Vécsei, L; Miller, A; Karussis, D; Chapman, J; Ghezzi, A; Comi, G; Gallo, Paolo; Cosi, V; Durelli, L; Anten, B; Visser, L; Myhr, Km; Szczudlik, A; Selmaj, K; Stelmasiak, Z; Podemski, R; Maciejek, Z; Cunha, L; Sega Jazbec, S; Montalba, X; Arbizu, T; Saiz, A; Bárcena, J; Arroyo, R; Fernández, O; Izquierdo, G; Casanova, B; Lycke, J; Kappos, L; Mattle, H; Beer, K; Coleman, R; Chataway, J; O'Riordan, J; Howell, S. .